LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - UroGen Pharma (NASDAQ: URGN)

Follow NASDAQ:URGN Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ URGN UroGen Pharma
Degnan Chris / officer: Chief Financial Officer
10/08/2025
Sell
$16.85
2,203
$37K
2,280
NASDAQ URGN UroGen Pharma
Schoenberg Mark / officer: Chief Medical Officer
09/08/2025
Sell
$19.11
871
$17K
149,025
NASDAQ URGN UroGen Pharma
Smith Jason Drew / officer: General Counsel
09/08/2025
Sell
$19.11
1,520
$29K
43,305
NASDAQ URGN UroGen Pharma
Wildman Daniel George / director
08/26/2025
Buy
$19.50
10,000
$195K
10,000
NASDAQ URGN UroGen Pharma
Robinson James A. Jr. / director
08/26/2025
Buy
$19.50
10,000
$195K
10,000
NASDAQ URGN UroGen Pharma
Holden Stuart / director
08/26/2025
Buy
$19.50
10,000
$195K
10,000
NASDAQ URGN UroGen Pharma
BUTITTA CYNTHIA M / director
08/26/2025
Buy
$19.50
10,000
$195K
10,000
NASDAQ URGN UroGen Pharma
WEN LEANA / director
08/26/2025
Buy
$19.50
10,000
$195K
10,000
NASDAQ URGN UroGen Pharma
Belldegrun Arie / director
08/26/2025
Buy
$19.50
20,000
$390K
20,000
NASDAQ URGN UroGen Pharma
Schoenberg Mark / officer: Chief Medical Officer
08/11/2025
Sell
$17.69
10,000
$177K
148,229

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous